INTRODUCTION
The mammalian heart synthesizes and secretes an array of cyclooxygenase products, notably prostacyclin (PGI2) and prostaglandin E2 (PGE2), eicosanoids that exhibit potent vasoactive effects (van Bilsen et al., 1989) . Endogenous production of these compounds depends primarily on the enzymic release of arachidonate from cellular phospholipids, and various studies suggest that glycerophospholipid and tissue-specific phospholipases (A2, C and/or D) are implicated in this step (Exton, 1990; Dennis et al., 1991; Currie et al., 1992) .
Many stimuli inducing increased phospholipase activity also activate the phospholipid-dependent and calcium-sensitive serine/threonine protein kinase C (PKC) (for review see Kikkawa et al., 1989) . Molecular cloning and biochemical analysis have shown that PKC represents a family of at least eight discrete enzymic subspecies exhibiting distinct structures, modes of activation, substrate specificities and tissue distributions (Nishizuka, 1988) . PKC isoenzymes are categorized into two groups, according to the presence or the absence of the N-terminal conserved sequence required for the enzyme's activation by calcium. The former group consists of calcium-sensitive PKC a, /3I, fII and y, while the latter comprises calcium-insensitive PKC 8, c, y and C (Kikkawa et al., 1989) .
Activation of PKC is concomitant with increased phospholipid hydrolysis and/or eicosanoid production in numerous cell types, including vascular smooth muscle cells (Lang and Vallotton, 1989) , glomerular mesangial cells (Gronich et al., 1988) , renal endothelial cells (Parker et al., 1987) and pinealocytes (Ho and Klein, 1987) . Conversely, the inhibition of PKC by various selective inhibitors (Parker et al., 1987; Halenda et al., 1989) , as well as the down-regulation of the enzyme by prolonged ac-11 ,13-eicosatetraenoic acid (1 5-HETE), prostaglandin E2 (PGE2) and prostacyclin (PGI2) generation, suggesting that one or more of these isoenzymes directly or indirectly activates a PLA2 in these cells. Confirming this, 4,-phorbol 12-monoacetate and 4a-phorbol had no effect on cellular eicosanoid formation, while the PMA-induced response was fully abolished both in the presence of the PKC inhibitors staurosporine and CGP 41251 and in PKC-down-regulated cells. PKC a, a and/or C therefore appear to play an important role in the PMA-mediated activation of cardiomyocyte PLA2, an event leading to subsequent production of PGI2, PGE2, 15-HETE, lyso-PC and PAF in this tissue.
tivation with tumour-promoting phorbol diesters, induces a powerful inhibition of arachidonate release (Godson et al., 1990) , suggesting that active PKC is required for the normal cellular synthesis of eicosanoids. In view of both the heterogeneity and the specific subcellular distribution of the PKC isoenzyme family (Nishizuka, 1988; Mochly-Rosen et al., 1990) , it is likely that certain PKC isoenzymes carry out distinct functions in the modulation of cellular phospholipid hydrolysis (Godson et al., 1990; Huwiler et al., 1991) .
Little is known about the intracellular signalling mechanisms controlling myocardial prostaglandin production. A 40kDa glycerophospholipid-specific myocardial phospholipase A2 (PLA2) has been purified and characterized (Hazen et al., 1990 (Hazen et al., , 1991 . While this enzyme appears to be mainly calciuminsensitive, it is activated by hypoxia, a condition known to activate PKC in other tissues (Louis et al., 1988; Cardell et al., 1991) . It 
Cell culture
Neonatal rat cardiomyocytes were obtained from 1-2-day-old Wistar rats according to Kem et al. (1991) . The majority of cultured cells (i.e. > 90%) began to spontaneously contract within 24 h of plating (40-80 beats/min), released atrial natriuretic peptide (ANP; 5 ng/h per 106 cells) and exhibited positive staining for pro-ANP, a precursor form of aANP and a specific cardiomyocyte marker. PGI2 production co-purified with cellular ANP secretion when mesenchymal cells were eliminated from culture according to Blondel et al. (1971) , indicating that PGI2 production originates from myoblasts and not from contaminating cell types. Substantiating this, cultured myocytes did not contain e-type PKC (a rat fibroblast marker; Borner et al., 1992) or bind acetylated low-density lipoprotein (endothelial cell marker; Stein and Stein, 1980) , while phorbol diester-induced PGI2 production was strongly correlated with ANP release (r = 0.93, P < 0.0005, n = 9). Confluent cells were used on the third day of culture for all experiments described herein.
Determination of eicosanoid formation Six-well tissue culture plates containing spontaneously beating confluent cardiomyocyte monolayers (-0.4 mg of cell protein/ well) were washed and incubated for 10 min at 37°C with 2 ml of Krebs-Ringer buffer containing 0.2 % (w/v) BSA and 0.2 % (w/v) glucose. After replacing the supernatant with 1 ml of fresh buffer, the cells were incubated at 37°C for the indicated times in the presence ofthe various pharmacological agents. Eicosanoid release was determined according to radioimmunological methods previously described (Wuthrich et al., 1986) , or as described in the various kits (Amersham). As a control, qualitative t.l.c. analysis of cardiomyocyte eicosanoid production was performed by extracting eicosanoids from 2 litres ofPMA-stimulated culture medium, followed by separation using the ethyl acetate-based solvent system described by Hurst et al. (1987) . T.l.c. results paralleled those obtained by radioimmunoassay.
Subcellular fractionation and determination of PKC activity
PMA-stimulated cells were subfractionated as previously de- scribed (Lang and Vallotton, 1989) . Semi-purification of PKC was carried out by DEAE-Sepharose chromatography according to the method of Godson et al. (1990) . Eluates were assayed for PKC activity by measuring phosphorylation of histone III-S in the presence and absence of lipid activators, as described by Lang and Vallotton (1989) .
Electrophoresis and immunoblotting Protein extracts were separated by SDS/PAGE on a 10 % slab gel and transferred to nitrocellulose membranes according to the method of Towbin et al. (1979) . Anti-PKC antibody binding was carried out according to Borner et al. (1992) , using monoclonal antibodies specifically directed against PKC isoforms a, /3 (/31 and /3ll) and y, or polyclonal rabbit antibodies specifically directed against PKC 8, e and C peptide segments. Following incubation with 1254-labelled sheep antibody, membranes were washed and autoradiographed at -70°C for either 3-4 days (PKC a, /3, 8 and ) or > 30 days (PKC y and e). Alternatively, anti-PKC antibody binding was detected by incubating membranes with either HRP-conjugated anti-rabbit IgG (for PKC 8, e and 0 or alkaline phosphatase-conjugated anti-mouse IgG (for PKC a, /3 and y), followed by colorimetric detection (Bio-Rad).
Lysophosphatldylcholine (lyso-PC) and PAF determination Lyso-PC and PAF determinations were carried out according to the method of Ho and Klein (1987) , modified for lyso-PC determination in cultured cells. Preconfluent monolayers (90 mm Petri dishes; second day of culture) were labelled for 24 h with 5 ml of McCoy's modified 5A medium containing [3H]choline (10 Ci/ml) and stimulated for the indicated times with 0.1 tM PMA. Cellular phospholipids were extracted in chloroform/ methanol (2: 1, v/v), and PC, lyso-PC and PAF were separated by t.l.c. using a chloroform/methanol/acetic acid/water (55:43:4:3, by vol.) solvent system. While adequate separation of authentic bovine heart PC, lyso-PC and PAF was achieved (RF values of 0.33, 0.05 and 0.2 respectively), lyso-PAF comigrated with lyso-PC in this system. Plasmalogen contaminants present in the PC standard could not be resolved from authentic PC (results not shown). Results were analysed by means of a Berthold linear t.l.c. analyser, as well as by scraping and scintillation counting. As a control, radioimmunological determination of PMA-induced PAF formation was carried out by assaying nitrogen-dried chloloform/methanol extracts resuspended in 100,ul of Tris/HCl buffer (pH 7.4). (Figure la) . The response was biphasic, with maximal activation of PKC at 15 min (+ 58 + 8.3 %, n = 8) being followed by the rapid disappearance of membranous PKC activity at 60 min (-70 + 7.4 %, ti = 12 min, n = 4). Overall, the increase in particulate-bound PKC activity was accompanied by a corresponding decrease in cytosolic PKC activity (-64.4 + 6.8 % at 15 min, n = 8).
Statistical analysis
Immunoblotting experiments indicated that cultured cells contain PKC isoforms a, /3, a and C (-80 kDa bands; Figure  lb) . PKC y and e were not detected in particulate or cytosolic Figure 2 ) and in a scintillation proximity assay (from 22.0 + 5.3 to 85.1 + 10.6 pg/h per mg of cell protein; n = 3). As shown in Figure 3 (a), PMA-induced eicosanoid generation exhibited kinetics identical to those observed for PMA-induced PAF production. PMA-induced PGI2 generation was sustained throughout and beyond 1 h incubations (+ 198 + 38 % at 1 h; n = 8), as cardiomyocytes continued to produce PGI2 for up to 3 h after the initial stimulation (+ 243 + 65 % at 3 h; n = 4; results not shown). The response was found to be concentrationdependent (Figure 3b) , with the EC50 for PMA-induced 6-oxo-PGF1. production being estimated at 2 + 0.5 nM (n = 6).
PMA-stimulated rat cardiomyocytes also exhibited increases in the synthesis and secretion of PGE2 (from 33.2+ 15.6 to 242.2 + 36.2 pg/h per mg of cell protein; n = 4) and 15-HETE (from 55.0+ 12.4 to 132.2+ 15.6 pg/h per mg of cell protein; n = 3), and to a lesser extent of thromboxane B2 (from 2.1 + 1.8 to 4.6 + 2.0 pg/h per mg of cell protein; increase insignificant at n = 3). While PGD2, PGF2. and the peptidoleukotrienes LTC4, LTD4 and LTE4 were not detected by direct radioimmunoassay of the stimulation media, qualitative t.l.c. analysis indicated that trace amounts of PGF2., were released into the media of PMAstimulated cells (results not shown).
Mechanism of phorbol diester-induced PGI2 production
We further investigated the specificity of PMA-induced cardiomyocyte PGI2 production by incubating cells with 4,8-phorbol 12-monoacetate and 4a-phorbol, which are inactive PMA analogues lacking the diester configuration and/or the 4,/ stereochemistry required for specific PKC binding and activation (Nishizuka, 1988) . As expected, 1 uM concentrations of both 4,/-phorbol 12-monoacetate and 4a-phorbol were ineffective in promoting 6-oxo-PGF1a production (Table 1) . Conversely, the active PMA analogue 4,/-phorbol 12,13-dibutyrate (PDBu; Figure 3 Phorbol diester-Induced 6-oxo-PGF1, production (4) PMA ( 0.1 ,uM) mimicked PMA-induced PGI2 release (238 + 57%; n = 4), while the PKC inhibitors CGP 41251 and staurosporine totally abolished PDBu-and/or PMA-induced 6-oxo-PGF1a production in these cells (Table 1) . Finally, PMA-induced PGI2 production was also inhibited in the presence of the purported PLA2 inhibitor quinacrine (10 ,M; 94.2% inhibition, see Table  1 ), a compound which failed to inhibit semi-purified PKC when tested in the activity assay used in establishing the time course of PKC activation shown in Figure 1 (activities: semi-purified PKC, 13 862+2405 c.p.m./10 min per mg of protein; semi-purified PKC+ 10uM quinacrine, 14989+2604 c.p.m./10 min per mg of protein; n = 3).
As a final control, we tested the effect of PKC down-regulation on PMA-induced PGI2 production. course of PMA-induced PKC activation depicted in Figure 1 , and suggests that PMA-induced PGI2 generation is inversely correlated to the amount of cytosolic PKC which is available for translocation to the membranous fraction.
DISCUSSION
Our results strongly suggest that phorbol diester-induced PGI2 production in cultured neonatal rat cardiomyocytes is a PKC a-, d-and/or c-dependent, PLA2-mediated process. This is supported by evidence that activation of these isoenzymes occurs simultaneously with increases in lyso-PC, PAF, PGI2, PGE2 and 15-HETE formation. Indeed, PMA-induced PGI2 generation and PAF production exhibit strikingly similar kinetic profiles, suggesting that a PLA2 is involved in PMA-induced eicosanoid generation in these cells. Furthermore, PMA-induced PGI2 generation displays an EC50 consistent with the Kd for phorbol diester binding in this tissue (-2 nM; see Limas and Limas, 1986) , while the inactive phorbol ester analogues 4f-phorbol 12-monoacetate and 4a phorbol had no effect on PGI2 release. Finally, PMA-induced PGI2 production was massively inhibited by the PKC inhibitors CGP 41251 and staurosporine, by the PLA2 inhibitor quinacrine and by down-regulation of cellular PKC activity.
Our findings are consistent with previous reports indicating that phorbol diester-induced activation ofcalcium-sensitive PKC a is concomitant with increased arachidonic acid release, prostaglandin formation and/or lysophospholipid production in both canine kidney endothelial cells and rat mesangial cells (Godson et al., 1990; Huwiler et al., 1991) . However, our results further indicate that the calcium-insensitive a and C PKC isoenzymes may also play a role in PKC-mediated PLA2 activation. Interestingly, we have found that simultaneous activation of PKC isoforms a, a and a also occurs in phorbol diester-stimulated rat aortic smooth muscle and transformed Chinese hamster ovary cells (D. J. Church and U. Lang, unpublished work) . In this light, it is likely that one of these isoforms is at the basis of PMAinduced PLA2 activation, as all three isoenzymes are either widely or universally expressed (Kikkawa et al., 1989; Mizuno et al., 1991) , and a voluminous literature attests to the multitude of tissues generating lysophospholipids upon activation of PKC.
Short-term (10-20 min) phorbol diester-induced myocardial PKC activation has previously been described in both beating rat heart and cultured cardiomyocytes (Yuan et al., 1987; Capogrossi et al., 1990) . To the best of our knowledge, the present study constitutes the first full description of the rapid kinetics of PKC down-regulation in cultured spontaneously beating rat cardiomyocytes. While PMA induced a biphasic response in terms of membranous PKC activation in these cells, the disappearance ofmembranous cardiomyocyte PKC activity occurs more rapidly than that observed in other tissues (Lang and Vallotton, 1989) . Furthermore, the finding that cultured cardiomyocytes contain ac, a and a 80 kDa PKCs, as well as relatively large amounts of various isoenzymic forms of PKM, is in agreement with previous immunoblotting, chromatographic and immunocytochemical studies performed with rat and bovine heart tissue (Girard et al., 1986; Mochly-Rosen et al., 1990; Allen and Katz, 1991; Mizuno et al., 1991) . While the existence ofmyocardial calcium-insensitive PKC e has previously been inferred by Northern blotting analysis of rat myocardium (Schaap et al., 1989) (Oishi et al., 1988; Shinomura et al., 1991 The hypothesis that PKC activation leads to increased PLA2 activity in cultured cardiomyocytes is re-inforced by the finding that PMA-induced eicosanoid production occurs simultaneously with cellular lyso-PC and PAF formation. While the inhibitory effects of both staurosporine and quinacrine support this, both compounds are noted for their relative lack of specificity. However, CGP 41251 exhibits high specificity for PKC (Meyer et al., 1989) , while quinacrine (10 uM) failed to inhibit purified PKC when tested in the in vitro PKC assay system used in this study. Taken together, it appears that PKC is indeed directly or indirectly activating a PLA2 in cultured cardiomyocytes.
There is reason to believe that the cardiac PLA2 involved in PMA-induced lysophospholipid and eicosanoid production is considerably different from the cellular PLA2s that have been identified, purified and characterized from other sources (Gronich et al., 1988; Halenda et al., 1989; Clark et al., 1991) . Although the subcellular distribution of the 40 kDa cardiac PLA2 appears to be calcium-sensitive (Hazen et al., 1991) , the activity of this enzyme is unaffected by calcium concentration, making it one of the few calcium-insensitive cellular PLA2s discovered to date. In this context, the calcium ionophore A23 187 is a remarkably poor stimulator of eicosanoid production in these cells (Church et al., 1991) .
Clearly, further studies need to be performed in order to determine whether the PCK-activated myocardial PLA2 inferred by our studies bears a relationship to any of the receptors for activated PKC recently detected in neonatal rat heart tissue (Mochly-Rosen et al., 1991) . In view of both the subcellular localization of activated 40 kDa myocardial PLA2 (Hazen et al., 1990 ) and the fact that PKC activation leads to the phosphorylation of a 40-45 kDa sarcolemmal protein in both canine and avian cardiac tissue (Iwasa and Hosey, 1984; Yuan and Sen, 1986) , myocardial PLA2 may indeed be a substrate for cc-, d-or c-type PKC.
